Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2026-02-08 Director's Dealing
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
4 Statement of changes in beneficial ownership 2 pages 12.1KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the United States Securities and Exchange Commission (SEC). Form 4 is used to report changes in beneficial ownership of company securities by directors, officers, or significant shareholders. The text includes details of a transaction by a director of ResMed Inc, including the number of shares disposed of and the transaction date. This type of filing is specifically related to insider trading or director dealings. Therefore, the document fits the category of Director's Dealing (DIRS). The document length and content confirm it is the actual filing, not just an announcement or certification.
2026-02-08 English
144 Report of proposed sale of securities 2 pages 146.4KB
Director's Dealing Classification · 100% confidence The document is a Form 144 filing with the SEC, which is a notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. It details the sale of securities by an insider or affiliate, including information about the securities, the seller, and the transaction dates. This type of filing is specifically related to insider transactions and personal share dealings by company directors or executives. It is not an annual report, earnings release, or any other financial report. Therefore, the correct classification is Director's Dealing (DIRS). The document length and content confirm it is the actual filing, not just an announcement or certification.
2026-02-05 English
144 Report of proposed sale of securities 2 pages 146.8KB
Director's Dealing Classification · 100% confidence The document is a Form 144 filing with the SEC, which is a notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. It details insider sales of securities by a director, including number of shares, dates, and broker information. This type of filing is specifically about personal share transactions by company directors or insiders. It is not an earnings release, annual report, or any other financial report. Therefore, it fits the definition of Director's Dealing (DIRS). The document length is 4455 characters, which is consistent with a detailed insider transaction report. Confidence is high due to the clear identification of Form 144 and insider sales information.
2026-02-05 English
Statement of CDIs on issue - RMD 3 pages 12.4KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 4A - Statement of CDIs on issue' and details the number and class of CHESS Depositary Interests (CDIs) and other securities on issue for ResMed Inc. It includes monthly statements of securities issued, net transfers, and reasons for changes such as stock options, employee stock purchase plans, and share repurchases. The document is a regulatory announcement related to securities on issue and changes in share capital but does not contain financial statements, management discussion, or detailed financial results. It is a formal regulatory filing about securities issued and changes in capital structure, consistent with announcements about share issues or capital changes. Given the content and the nature of the document, the most appropriate classification is 'Share Issue/Capital Change' (SHA). The document length is 3043 characters, which is short and focused on securities issued rather than a full report or announcement of a report publication.
2026-02-04 English
4 Statement of changes in beneficial ownership 2 pages 12.1KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the United States Securities and Exchange Commission (SEC). Form 4 is used to report changes in beneficial ownership of company securities by insiders such as officers, directors, or significant shareholders. The text includes details of a transaction by Brett Sandercock, Chief Financial Officer of ResMed Inc., reporting a sale of shares. This is a classic example of a Director's Dealing report, which documents insider transactions in company shares. The document does not contain financial statements, earnings data, or other report types. Therefore, the correct classification is Director's Dealing (DIRS).
2026-02-03 English
144 Report of proposed sale of securities 2 pages 148.6KB
Director's Dealing Classification · 100% confidence The document is a Form 144 filing with the SEC, which is a notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. It details the sale of securities by an insider or affiliate, including the number of shares, dates, and broker information. This type of filing is specifically related to insider transactions and personal share dealings by company directors or executives. It is not an earnings release, annual report, or any other financial report. Therefore, it fits the category of Director's Dealing (DIRS). The document length and content confirm it is the actual filing, not just an announcement or certification. Confidence is high due to the clear identification of Form 144 and insider sale details.
2026-02-02 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.